United StatesÚltimas notícias

Former Alameda Research CEO Caroline Ellison is set for early release from US custody in January following her conviction in the FTX collapse.

The Philippines has ordered ISPs to block Coinbase and Gemini, escalating a crackdown on unlicensed crypto exchanges operating in the country.

The NFA has accused Japan-based Forex Wizard of misleading investors, running an undisclosed forex pool and delaying a $500,000 withdrawal.

The CFTC has formally closed its six-year civil spoofing case against former JPMorgan metals traders, imposing fines and long-term market bans.

Binance has listed Kyrgyzstan’s som-pegged KGST stablecoin as the country accelerates legislation, reserves and national plans around digital assets.

Omeros Corporation (NASDAQ:OMER) said the U.S. Food and Drug Administration approved YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, marking the first authorized therapy for the life-threatening condition.

Repare Therapeutics (NASDAQ:RPTX) has entered into a definitive asset purchase agreement to sell its polymerase theta (Polθ) ATPase inhibitor, RP-3467, to Gilead Sciences (NASDAQ:GILD) for up to $30 million.

Edgewise Therapeutics (NASDAQ:EWTX) said it has completed Parts B and C of the CIRRUS-HCM study and reported favorable interim safety data from Part D for EDG-7500, its selective oral cardiac sarcomere modulator being developed for obstructive and nonobstructive hypertrophic cardiomyopathy

Stonepeak, the New York-based alternative investment firm, has reached an agreement to acquire a 65% controlling interest in Castrol from BP (NYSE:BP), the companies announced Wednesday.

Agios Pharmaceuticals (NASDAQ:AGIO) announced today that the U.S. Food and Drug Administration (FDA) has approved AQVESME™ (mitapivat) for the treatment of anemia in adults with alpha- or beta-thalassemia.

AST SpaceMobile (NASDAQ:ASTS) achieved a major milestone in the race for space-based cellular connectivity with the successful orbital launch of BlueBird 6 on Tuesday night.

Bitcoin is struggling below key technical levels near 87,500, with weak momentum and rising downside risks as traders remain cautious heading into year-end.